Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Enya Scanlon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial
Scanlon, E., Lavery, A., Albraikat, M., Stevenson, L., Kennedy, C., Byrne, R., Walker, A., Mullan-Young, B., McManus, D. T., Virdee, P. S., Elhussein, L., Turbitt, J., Collinson, D., Miedzybrodzka, Z., Van Schaeybroeck, S., McQuaid, S., James, J. A., Craig, S. G., Blayney, J. K. & Petty, R. D. & 6 others, , Nov 2024, In: ESMO Open. 9, 11, 14 p., 103930.Research output: Contribution to journal › Article › peer-review
Open AccessFile54 Downloads (Pure) -
Identification of Src as a therapeutic target in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches
McCabe, N. H., Stevenson, L., Scanlon, E., Douglas, R., Kennedy, S., Keminer, O., Windshügel, B., Zisterer, D., Kennedy, R. D., Blayney, J. K. & Turkington, R. C., 30 Jul 2022, In: Cancers. 14, 15, 18 p., 3726.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Link opens in a new tab Citations (Scopus)201 Downloads (Pure) -
Identification of Src's role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches
McCabe, N. H., Stevenson, L., Scanlon, E., Keminer, O., Kennedy, R. D., Windshuegel, B., Blayney, J. K. & Turkington, R. C., 15 Aug 2020, In: Cancer Research. 80, 16 Supplement, 2999.Research output: Contribution to journal › Meeting abstract › peer-review
7 Downloads (Pure) -
In silico drug repositioning using omics data: the potential and pitfalls
Scanlon, E. & Blayney, J., 2020, Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Revised and expanded (living reference work) ed. Springer NatureResearch output: Chapter in Book/Report/Conference proceeding › Entry for encyclopedia/dictionary
-
Defining an IBD-like subgroup in consensus molecular subgroups of colorectal cancer and transcriptomic biomarker development for at-risk patients
Scanlon, E., Murphy, S. J., Kennedy, R. D. & Blayney, J. K., 26 May 2019, In: Journal of Clinical Oncology. 37, 15_supplResearch output: Contribution to journal › Meeting abstract › peer-review
Activities
- 1 Participation in conference
-
Beyond Bias: Advancing Excellence in Health Sciences
Jeyaraj, P. (Session chair), Dombrowski, Y. (Organiser), Blayney, J. (Organiser), Lopez Campos, G. (Session chair), Roe, S. (Invited speaker), Corrigan, M. (Invited speaker), McCloskey, K. (Invited speaker), Sotonye-Frank, G. (Invited speaker), Scanlon, E. (Session chair) & Kennedy, N. (Invited speaker)
29 Sept 2025Activity: Participating in or organising an event types › Participation in conference
Thesis
-
A bioinformatics approach to identifying ulcerative colitis patients at-risk of developing colorectal cancer
Scanlon, E. (Author), Kennedy, R. (Supervisor) & Blayney, J. (Supervisor), Dec 2023Student thesis: Doctoral Thesis › Doctor of Philosophy
File